This article provides a protocol for the joint analysis of the prospective cohort studies of the ZIKAlliance, ZikaPLAN and ZIKAction consortia.
Neurodevelopmental milestones and associated behaviours are similar among healthy children across diverse geographical locations
by INTERGROWTH-21stThe latest findings from the international INTERGROWTH-21st Project, that has monitored healthy, urban children from educated families across four continents from early pregnancy to 2 years of age, show that human neurodevelopment is not influenced by the colour of an individual’s skin.
The risk of congenital neurologic defects related to Zika virus (ZIKV) infection has ranged from 6 to 42% in various reports. The aim of this study was to estimate this risk among pregnant women with symptomatic ZIKV infection in French territories in the Americas.
The key message from this study is that the large uncertainty around the risk estimate needs to be further investigated because of a) the possible existence of co-factors that are yet to be validated, b) the assumptions that the authors needed to make in the absence of good data for the proportion of women who were infected during pregnancy.
The key message from this study is that the large uncertainty around the risk estimate needs to be further investigated because of a) the possible existence of co-factors that are yet to be validated, b) the assumptions that the authors needed to make in the absence of good data for the proportion of women who were infected during pregnancy.
Malaria in Pregnancy Consortium Safety Tools and Resources
by Global PharmacovigilanceResearch in pregnant and breastfeeding women is a complex area, with both the wellbeing of the mother and child paramount. Careful monitoring of any intervention to treat, or prevent, illness is required to ensure the benefits outweigh any harms. Read this article to find out more and download some of the safety tools developed by experts from the Malaria in Pregnancy Consortium.
Zika and Other Emerging Viruses: Aiming at the Right Target
by Dallmeier & NeytsThe article argues that the off-label use of drugs that may protect against Zika virus-induced brain damage has to be balanced with their risk during pregnancy.
Become a CoLab Member
by Global Pregnancy CoLabWHAT IS THE GLOBAL PREGNANCY COLLABORATION (COLAB)? CoLab is a consortium of international investigative groups with data and biological samples from women prior to, during and in some cases, long after an adverse pregnancy outcome. These data and samples are in a membership-wide shared database and available to CoLab members and to investigators sponsored by CoLab members. We currently have members from over 35 centers with more than 300,000 pregnancies and we are growing! We believe the time has come in obstetrical research to pool research and intellectual resources to begin to address and answer questions that could not otherwise be answered by a single investigative group.
How to Get Data and/or Biological Samples
by Global Pregnancy CoLabHOW TO COLLABORATE? Applicants with research interests relevant to CoLab (complications of pregnancy) may apply to collaborate with CoLab. Please note that to obtain samples and/or data from CoLab cohorts, you will need a member of CoLab to be your sponsor. We can help assist you in getting a sponsor. All CoLab projects are considered collaborations and you will work directly with CoLab members and cohorts to obtain data and/or biological samples for your project. However, you will work directly with the CoLab office thorough the application process, to give quarterly updates, and to work with a protocol committee regarding your project.
Strategy for Standardization of Preeclampsia Research Study Design